Cargando…
Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
Autores principales: | Beard, Katherine, Sriwastava, Shitiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523307/ https://www.ncbi.nlm.nih.gov/pubmed/34688988 http://dx.doi.org/10.1016/j.jns.2021.120034 |
Ejemplares similares
-
A case series and literature review of multiple sclerosis and COVID-19: Clinical characteristics, outcomes and a brief review of immunotherapies
por: Kataria, Saurabh, et al.
Publicado: (2020) -
Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review
por: Kelsey, Andrew, et al.
Publicado: (2021) -
Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination
por: Podury, Sanjiti, et al.
Publicado: (2021) -
Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature
por: Sriwastava, Shitiz, et al.
Publicado: (2021) -
COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)